SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-032462
Filing Date
2023-06-30
Accepted
2023-06-30 16:30:21
Documents
12
Period of Report
2023-06-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K brhc20055271_8k.htm   iXBRL 8-K 34008
  Complete submission text file 0001140361-23-032462.txt   172461

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA infi-20230627.xsd EX-101.SCH 3853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE infi-20230627_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE infi-20230627_pre.xml EX-101.PRE 16036
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc20055271_8k_htm.xml XML 4231
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 231062180
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences